146 related articles for article (PubMed ID: 37922849)
1. POSS engineering of squaraine nanoparticle with high photothermal conversion efficiency for photothermal therapy.
Gu Z; Tian X; Guang S; Wei G; Mao Y; Xu H
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Feb; 306():123576. PubMed ID: 37922849
[TBL] [Abstract][Full Text] [Related]
2. POSS Engineering of Multifunctional Nanoplatforms for Chemo-Mild Photothermal Synergistic Therapy.
Gu Z; Geng X; Guang S; Xu H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256086
[TBL] [Abstract][Full Text] [Related]
3. Azulene-Containing Squaraines for Photoacoustic Imaging and Photothermal Therapy.
Yao Y; Zhang Y; Zhang J; Yang X; Ding D; Shi Y; Xu H; Gao X
ACS Appl Mater Interfaces; 2022 May; 14(17):19192-19203. PubMed ID: 35438482
[TBL] [Abstract][Full Text] [Related]
4. Fluorination Enhances NIR-II Emission and Photothermal Conversion Efficiency of Phototheranostic Agents for Imaging-Guided Cancer Therapy.
Li C; Jiang G; Yu J; Ji W; Liu L; Zhang P; Du J; Zhan C; Wang J; Tang BZ
Adv Mater; 2023 Jan; 35(3):e2208229. PubMed ID: 36300808
[TBL] [Abstract][Full Text] [Related]
5. Near-Infrared Light-Driving Organic Photothermal Agents with an 88.9% Photothermal Conversion Efficiency for Image-Guided Synergistic Phototherapy.
Zhao X; Sun M; Cao X; Xu J; Li X; Zhao X; Lu H
Adv Healthc Mater; 2024 Mar; ():e2400201. PubMed ID: 38519419
[TBL] [Abstract][Full Text] [Related]
6. Acceptor-donor-acceptor type organic photothermal agents with enhanced NIR absorption and photothermal conversion effect for cancer photothermal therapy.
Sun M; Zhao X; Cao X; Li X; Xu J; Meng X; Lu H; Zhao X
Talanta; 2024 Jul; 274():125991. PubMed ID: 38547836
[TBL] [Abstract][Full Text] [Related]
7. The self-assembly of a hybrid photosensitizer for the synergistically enhanced photodynamic/photothermal therapy.
Chen J; Cui Y; Song K; Liu T; Zhou L; Bao B; Wang R; Wang L
Biomater Sci; 2021 Mar; 9(6):2115-2123. PubMed ID: 33481965
[TBL] [Abstract][Full Text] [Related]
8. Low Power Single Laser Activated Synergistic Cancer Phototherapy Using Photosensitizer Functionalized Dual Plasmonic Photothermal Nanoagents.
Younis MR; Wang C; An R; Wang S; Younis MA; Li ZQ; Wang Y; Ihsan A; Ye D; Xia XH
ACS Nano; 2019 Feb; 13(2):2544-2557. PubMed ID: 30730695
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable π-Conjugated Oligomer Nanoparticles with High Photothermal Conversion Efficiency for Cancer Theranostics.
Li X; Liu L; Li S; Wan Y; Chen JX; Tian S; Huang Z; Xiao YF; Cui X; Xiang C; Tan Q; Zhang XH; Guo W; Liang XJ; Lee CS
ACS Nano; 2019 Nov; 13(11):12901-12911. PubMed ID: 31682416
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular adducts of squaraine and protein for noninvasive tumor imaging and photothermal therapy in vivo.
Gao FP; Lin YX; Li LL; Liu Y; Mayerhöffer U; Spenst P; Su JG; Li JY; Würthner F; Wang H
Biomaterials; 2014 Jan; 35(3):1004-14. PubMed ID: 24169004
[TBL] [Abstract][Full Text] [Related]
11. Hafnium carbide nanoparticles for noninflammatory photothermal cancer therapy.
Ma Y; Wu H; Guo Q; Dai X; Wang P; Zhang W; Liu D; Chen X; Qian H; Wang X
J Colloid Interface Sci; 2023 Dec; 651():47-58. PubMed ID: 37540929
[TBL] [Abstract][Full Text] [Related]
12. Near-Infrared Conjugated Polymers Containing Thermally Activated Delayed Fluorescence Units Enable Enhanced Photothermal Therapy.
Xu Y; Chen B; Su D; Li J; Qi Q; Hu Y; Wang Q; Xia F; Lou X; Zhao Z; Dai J; Dong X; Zhou J
ACS Appl Mater Interfaces; 2023 Dec; 15(48):56314-56327. PubMed ID: 37983087
[TBL] [Abstract][Full Text] [Related]
13. Biocompatible BSA-Ag
Zhao J; Zhang Q; Liu W; Shan G; Wang X
Colloids Surf B Biointerfaces; 2022 Mar; 211():112295. PubMed ID: 34952286
[TBL] [Abstract][Full Text] [Related]
14. MoS
Sun L; Bai H; Jiang H; Zhang P; Li J; Qiao W; Wang D; Liu G; Wang X
Colloids Surf B Biointerfaces; 2022 Jun; 214():112462. PubMed ID: 35349941
[TBL] [Abstract][Full Text] [Related]
15. Polydopamine encapsulated new indocyanine green theranostic nanoparticles for enhanced photothermal therapy in cervical cancer HeLa cells.
Fan H; Yan T; Chen S; Du Z; Alimu G; Zhu L; Ma R; Tang X; Heng Y; Alifu N; Zhang X
Front Bioeng Biotechnol; 2022; 10():984166. PubMed ID: 36213060
[TBL] [Abstract][Full Text] [Related]
16. Side-chain engineering of organic photothermal agents for boosting further red-shifted absorption and higher photothermal therapeutic effect.
Tang C; Pan Y; Wei Z; Liu L; Xu J; Han W; Cai Y
Colloids Surf B Biointerfaces; 2024 Jan; 233():113611. PubMed ID: 37924748
[TBL] [Abstract][Full Text] [Related]
17. A highly efficient polydopamine encapsulated clinical ICG theranostic nanoplatform for enhanced photothermal therapy of cervical cancer.
Du Z; Ma R; Chen S; Fan H; Heng Y; Yan T; Alimu G; Zhu L; Zhang X; Alifu N; Ma C
Nanoscale Adv; 2022 Sep; 4(18):4016-4024. PubMed ID: 36133329
[TBL] [Abstract][Full Text] [Related]
18. Antitumor Applications of Photothermal Agents and Photothermal Synergistic Therapies.
Li C; Cheng Y; Li D; An Q; Zhang W; Zhang Y; Fu Y
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887255
[TBL] [Abstract][Full Text] [Related]
19. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
[TBL] [Abstract][Full Text] [Related]
20. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
